Skip to main content
Tuberculosis in Tondo, Manila - Ezra Acayan
Tuberculosis (TB) is one of the world’s biggest global health crises. Killing 1.3 million people in 2022, TB is the world’s second deadliest infectious disease after COVID-19.

Obsolete treatments, the lack of an effective vaccine, and the lack of suitable diagnostic tools make it difficult to control the global TB epidemic. In 2022, 7.5 million people across 192 countries and areas were diagnosed with TB.
 
Some gains have been made in recent years; the first new TB drugs in half a century and the trial of a shorter course of treatment for drug-resistant TB. But the harsh reality remains - 10.6 million people fell sick with TB and 410,000 developed multidrug-resistant TB (MDR-TB) in 2022, which is much harder to treat. Only about one-third of people with DR-TB accessed treatment in 2021. The majority go undiagnosed and therefore untreated.

Tuberculosis

Quick facts about tuberculosis

 
Uzbekistan

“Please, never give up. You too can beat TB.”

Voices from the Field 6 Aug 2015
 
Myanmar

MSF assisting thousands as worst flooding in decades hits parts of the country

Project Update 4 Aug 2015
 
Democratic Republic of Congo

MSF has vaccinated over 287,000 children against measles in four provinces

Project Update 3 Aug 2015
 
Mali

MSF continues its activities in Timbuktu despite insecurity

Project Update 24 Jul 2015
 
HIV/AIDS

MSF warns successful global HIV response will require bigger emphasis on adherence

Press Release 21 Jul 2015
 
Belgium

Countries, beware: Climbing up the income ladder can seriously damage your health!

Voices from the Field 13 Jul 2015
 
New Treatment for XDR-TB Patients in Grozny
Tuberculosis

“I’ve been sick for more than 15 years - my goal is to be cured.”

Voices from the Field 8 Jul 2015
 
TB in Grozny, Chechnya - December 2011
Tuberculosis

New TB drug regimen helps patients with extensive resistance to treatment

Press Release 8 Jul 2015
 
My Life With HIV: Carmen slideshow pictures
Access to medicines

Why MSF needs India to remain open for business

Report 1 Jul 2015
fieldresearch.msf.org

We produce important research based on our field experience. So far, we have published articles in over 100 peer-reviewed journals. These articles have often changed clinical practice and have been used for humanitarian advocacy. Read all our Tuberculosis-related articles on our dedicated Field Research website.

View site
Osh project, fighting TB